<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05039034</url>
  </required_header>
  <id_info>
    <org_study_id>SMDC</org_study_id>
    <nct_id>NCT05039034</nct_id>
  </id_info>
  <brief_title>Screening and Management of High-risk Populations of Stroke in Dehui City</brief_title>
  <acronym>SAMHPSDC</acronym>
  <official_title>Screening and Management of High-risk Populations of Stroke in Dehui City</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yi Yang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dehui People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of&#xD;
      risk factors in sampling population aged 40 years and over (born before December 31,1975) in&#xD;
      Dehui City, to provide scientific basis for pertinent prevention and control of stroke in&#xD;
      Jilin Province, and to provide valuable data for the high-risk groups to carry out regular&#xD;
      follow-up and standardized management.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Prevalence rate of stroke</measure>
    <time_frame>4 months</time_frame>
    <description>The proportion of stroke in the general population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence rate of hypertension</measure>
    <time_frame>4 months</time_frame>
    <description>The proportion of hypertension in the general population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence rate of diabetes mellitus</measure>
    <time_frame>4 months</time_frame>
    <description>The proportion of diabetes mellitus in the general population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence rate of dyslipidemia</measure>
    <time_frame>4 months</time_frame>
    <description>The proportion of dyslipidemia in the general population.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">4100</enrollment>
  <condition>Cerebrovascular Accident</condition>
  <condition>Stroke</condition>
  <condition>Hypertension</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>Low-risk Group</arm_group_label>
    <description>Low-risk Group is defined as the population with &lt;3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but without chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mediate-risk Group</arm_group_label>
    <description>Mediate-risk Group is defined as the population with &lt;3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but meanwhile suffer from chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-risk Group</arm_group_label>
    <description>High-risk Group is defined as the population with â‰¥3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), or population with history of stroke or/and transient ischemic attack.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Advice according to primary prevention guidelines on stroke of China</intervention_name>
    <arm_group_label>High-risk Group</arm_group_label>
    <arm_group_label>Low-risk Group</arm_group_label>
    <arm_group_label>Mediate-risk Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Target population aged 40 years and over (born before December 31,1975) was selected from&#xD;
        Dehui City by means of group sampling.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 40 years and over in Dehui City&#xD;
&#xD;
          -  Willing to participate in the study and follow-up visits&#xD;
&#xD;
          -  Signed an informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Life expectancy&lt;3 years&#xD;
&#xD;
          -  Unwilling to participate in the study and follow-up visits&#xD;
&#xD;
          -  Living away from Dehui City over 6 months&#xD;
&#xD;
          -  Unable to cooperate with examination and questionnaire due to mental disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Yang, M.D. Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>The First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ying-Qi Xing, M.D. Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>The First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhen-Ni Guo, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>The First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fu-Liang Zhang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hao-Yuan Liu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Hospital of Jilin University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Yi Yang</investigator_full_name>
    <investigator_title>Associated Dean of First Hospital of Jilin University</investigator_title>
  </responsible_party>
  <keyword>Stroke/epidemiology</keyword>
  <keyword>Stroke/prevention and control</keyword>
  <keyword>Risk Factors</keyword>
  <keyword>Cognition</keyword>
  <keyword>Surveys and Questionnaires</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

